Duquesne
NTRA · Health care

Natera

Makes DNA blood tests for pregnancy, cancer and organ transplants.
Bought more
Duquesne owns 3.2 million shares of Natera, worth about $865 million. That’s $20 of every $100 they have in stocks — their biggest bet. Between April and June they bought 122,700 more (up 4%).
Mar 31
3,063,606
Jun 30
3,186,306

The numbers

Shares they own
3,186,306
Change since Mar 31
+122,700
+4.0%
Shares on Mar 31
3,063,606
Value on Jun 30, 2026
$864,923,000
about $865 million
Share of their money
19.9%
$20 of every $100 · Biggest of 85
Price per share on Jun 30
$271.45
Cost of the shares they added
about $33 million
at the Jun 30 price
Kind
Shares
More about Natera
The value uses the price on Jun 30, 2026. The fund may have paid a different price.
Not investment advice. Holdings come from public SEC reports and the funds’ own letters, and can be up to 4½ months old. How this works